These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25250305)

  • 1. Extra-renal manifestations of complement-mediated thrombotic microangiopathies.
    Hofer J; Rosales A; Fischer C; Giner T
    Front Pediatr; 2014; 2():97. PubMed ID: 25250305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-renal manifestations of atypical hemolytic uremic syndrome.
    Formeck C; Swiatecka-Urban A
    Pediatr Nephrol; 2019 Aug; 34(8):1337-1348. PubMed ID: 30109445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare Presentation of Atypical Hemolytic Uremic Syndrome in an Adult.
    Alhabhbeh A; Fatima Z; Thomas A; Cook C
    Cureus; 2021 Sep; 13(9):e18184. PubMed ID: 34589371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy.
    Kichloo A; Chugh SS; Gupta S; Pandav J; Chander P
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842905. PubMed ID: 31010328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
    Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D
    Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-mediated thrombotic microangiopathy associated with lupus nephritis.
    Park MH; Caselman N; Ulmer S; Weitz IC
    Blood Adv; 2018 Aug; 2(16):2090-2094. PubMed ID: 30131343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
    Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
    Front Immunol; 2019; 10():240. PubMed ID: 30858847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative pathway of complement and the thrombotic microangiopathies.
    Teoh CW; Riedl M; Licht C
    Transfus Apher Sci; 2016 Apr; 54(2):220-31. PubMed ID: 27160864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
    Shen YM
    Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Atypical Hemolytic Uremic Syndrome.
    Yoshida Y; Kato H; Ikeda Y; Nangaku M
    J Atheroscler Thromb; 2019 Feb; 26(2):99-110. PubMed ID: 30393246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.
    Sakurai S; Kato H; Yoshida Y; Sugawara Y; Fujisawa M; Yasumoto A; Matsumoto M; Fujimura Y; Yatomi Y; Nangaku M
    J Atheroscler Thromb; 2020 Apr; 27(4):353-362. PubMed ID: 31484852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo thrombotic microangiopathy after kidney transplantation.
    Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
    Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.